With some analysts predicting a weight-loss market reaching $100 billion a year or more by the end of the decade, executives at Sun Pharma, Cipla, Dr Reddy#39;s and Lupin — some of the world#39;s largest generic drugmakers — all said they have started work on Wegovy versions.